News
Study finds the GLP-1 drug liraglutide reduced migraine days by almost 50% in patients with obesity, with quality of life ...
The Delhi High Court on Wednesday directed the Central Drugs Standard Control Organisation (CDSCO) to decide, within 3 months ...
The Delhi High Court has instructed India's drug regulator to address concerns about the approval process for drugs like ...
Weight loss drugs like Ozempic have gained a lot of popularity However these medications are not without side effects One ...
GLP-1RA use initially lowered delirium risk but eventually heightened delirium risk after 5 years among patients with type 2 diabetes.
Delhi High Court asks DCGI to consult experts on weight-loss drug combinations, addressing concerns over safety and approval ...
The Semaglutide market is projected to expand from US$ 27.15 billion in 2024 to US$ 61.7 billion by 2033, with a CAGR of 9.55% from 2025. Driven by r ...
I was just a baby scientist when I discovered the hormone that made Ozempic possible. I had no idea how life-changing—and world-changing—that ...
Ozempic has gained a lot of popularity with many referring to it as the miracle weight loss drug However how much do you ...
Obesity costs U.S. health care nearly $173 billion yearly. With more than 200 related complications such as heart disease, ...
1h
The Print on MSNObesity care in India is evolving—no longer just diets & surgery, it’s all about multi-specialty approachAs obesity management draws awareness and weight-loss injections are launched in India, hospitals are offering customised ...
Slim-Fast roared into the weight-loss market in the 1970s, and Mr. Abraham used his fortune to back Democratic candidates and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results